Patents Assigned to MedCan Pharma A/S
-
Publication number: 20200330423Abstract: The present invention relates to an oral tablet for delivery of cannabinoids to mucosal surfaces comprising a population of particles and one or more cannabinoids, the population of particles comprising a) directly compressible (DC) sugar alcohol particles and b) non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas.Type: ApplicationFiled: April 17, 2019Publication date: October 22, 2020Applicant: MedCan Pharma A/SInventors: Heidi Ziegler Brunn, Dorthe Schackinger Boesen, Ane Eriksen, Helle Wittorff
-
Patent number: 10799450Abstract: The present invention relates to a tableted chewing gum composition for oral administration of cannabinoids, the composition comprising a plurality of particles, including a first population of particles comprising water-insoluble gum base and a second population of particles comprising water-soluble chewing gum ingredients, and the composition constituting at least two layers, wherein a first layer of the composition comprises water-insoluble gum base and a second layer of the composition, which is cohered to and adjacent to the first layer, comprises water-soluble chewing gum ingredients, the second layer being free of water-insoluble gum base, and wherein the composition comprises one or more cannabinoids.Type: GrantFiled: March 1, 2019Date of Patent: October 13, 2020Assignee: MedCan Pharma A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20200316012Abstract: A powdered composition is disclosed, the powdered composition comprising a complex between one or more cannabinoids having at least one phenolic moiety and a basic ion exchange resin. Also, an orally dispensable delivery vehicle, a method of manufacturing the powdered composition, a method of manufacturing the orally dispensable delivery vehicle, composition for use as a medicament, composition for use in a treatment, method of treatment, and use of a basic ion exchange resin as a stabilizing agent are disclosed.Type: ApplicationFiled: May 27, 2016Publication date: October 8, 2020Applicant: MedCan Pharma A/SInventor: Søren Christian Schou
-
Publication number: 20200276117Abstract: The present invention relates to a method of producing a tableted chewing gum composition for oral administration of cannabinoids, the method comprises the steps of: i) feeding a gum composition comprising water-insoluble gum base into an extruder from one or more feeding inlets, optionally including additional ingredients, ii) pressurizing the gum composition in the extruder while controlling temperature and pressure of the gum composition, optionally including further ingredients from one or more feeding inlets, iii) extruding the gum composition through a die means, iv) cutting the extruded gum composition in a liquid filled chamber, thereby obtaining a first population of particles comprising water-insoluble gum base, v) including the first population of particles with a second population of particles comprising water-soluble chewing gum ingredients and one or more cannabinoids, the second population of particles being free of water-insoluble gum base, thereby obtaining a chewing gum composition and vi) tType: ApplicationFiled: March 1, 2019Publication date: September 3, 2020Applicant: MedCan Pharma A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20200276115Abstract: The present invention relates to a tableted chewing gum composition for oral administration of cannabinoids, the composition comprising water-soluble chewing gum ingredients and water-insoluble gum base located in a plurality of particles, wherein a first population of particles comprises water-insoluble gum base, including one or more polyvinyl acetate elastomer plasticizers, and a second population of particles comprises water-soluble chewing gum ingredients, the second population of particles being free of water-insoluble gum base, wherein the chewing gum composition comprises one or more cannabinoids.Type: ApplicationFiled: March 1, 2019Publication date: September 3, 2020Applicant: MedCan Pharma A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20200276116Abstract: The present invention relates to a tableted chewing gum composition for oral administration of cannabinoids, the composition comprising a plurality of particles, including a first population of particles comprising water-insoluble gum base and a second population of particles comprising water-soluble chewing gum ingredients, and the composition constituting at least two layers, wherein a first layer of the composition comprises water-insoluble gum base and a second layer of the composition, which is cohered to and adjacent to the first layer, comprises water-soluble chewing gum ingredients, the second layer being free of water-insoluble gum base, and wherein the composition comprises one or more cannabinoids.Type: ApplicationFiled: March 1, 2019Publication date: September 3, 2020Applicant: MedCan Pharma A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20200276118Abstract: The present invention relates to a tableted chewing gum composition for oral administration of cannabinoids, the composition comprising water-soluble chewing gum ingredients and water-insoluble gum base located in a plurality of particles, wherein the chewing gum composition comprises one or more cannabinoids, and wherein the release rate of the one or more cannabinoids is more than 20% by weight of the one or more cannabinoids within the first 5 minutes upon oral administration.Type: ApplicationFiled: March 1, 2019Publication date: September 3, 2020Applicant: MedCan Pharma A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20200276119Abstract: The present invention relates to a tableted chewing gum composition for oral administration of cannabinoids, the composition comprising water-soluble chewing gum ingredients and water-insoluble gum base located in a plurality of particles, wherein the chewing gum composition comprises one or more cannabinoids, and wherein the chewing gum composition generates saliva and delivers more than 20% by weight of the one or more cannabinoids to the oral mucosa during the first 5 minutes of chewing.Type: ApplicationFiled: March 1, 2019Publication date: September 3, 2020Applicant: MedCan Pharma A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20200237659Abstract: A chewing gum for mucosal delivery of cannabinoids, the chewing gum being formulated as an extruded chewing gum including water-soluble chewing gum ingredients mixed into water-insoluble gum base, wherein the chewing gum has one or more cannabinoids, and wherein the chewing gum generates saliva and delivers at least 10% by weight of the one or more cannabinoids to the oral mucosa during the first 5 minutes of chewing.Type: ApplicationFiled: January 25, 2019Publication date: July 30, 2020Applicant: MedCan Pharma A/SInventors: Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
-
Publication number: 20200000767Abstract: A liquid cannabinoid composition (LCC) is disclosed, said liquid cannabinoid composition (LCC) comprising a vaporizer carrier liquid (VCL), and a tetrahydrocannabinolic compound and/or a cannabidiolic compound, wherein at least 95 percent by weight of said tetrahydrocannabinolic compound and/or cannabidiolic compound is present in acid form. Also, a method of obtaining a liquid cannabinoid composition (LCC), a method of activating a liquid cannabinoid composition (LCC), use of liquid cannabinoid composition (LCC), a cannabinoid container comprising a liquid cannabinoid composition (LCC), and a personal vaporizer comprising such cannabinoid container are disclosed.Type: ApplicationFiled: December 20, 2017Publication date: January 2, 2020Applicant: MedCan Pharma A/SInventors: Søren Christian Schou, Heldi Ziegler Bruun